Mark Hoffman is a long-time CLL patient advocate and facilitator of the CLL Society Patient & Caregiver Support Group in San Diego, CA.
In this article from Cancer Health, Mark echoes the importance of the Test Before Treat™ campaign by sharing his story. When Mark was first diagnosed with CLL his local community hematologist/oncologist prescribed a combination of three chemotherapy drugs prior to ordering the correct genetic testing that would help determine if this treatment option, which can be harsh and damaging to the body, would help him.
Fortunately for Mark, through education from CLL Society Support Groups and his own research, he was able to advocate for his best possible care.
Please enjoy his story.